42 weeks post NTCELL implant: Data shows treatment has stopped the progression of Parkinson's in study patients

The four patients who took part in Living Cell Technologies Limited's Phase I/IIa clinical study of NTCELL(R) for Parkinson's disease have all reached the milestone of 42 weeks post-implant.
Source: Parkinson's Disease News From Medical News Today - Category: Neurology Tags: Parkinson's Disease Source Type: news